The global Veterinary Pharmacovigilance market size in 2023 is 881.9 million US dollars, and it is expected to be 1998.8 million US dollars by 2030, with a compound annual growth rate of 12.4% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Veterinary Pharmacovigilance market include Zoetis Inc., Merck & Co., Inc. (Merck Animal Health), Boehringer Ingelheim Animal Health, Elanco Animal Health, and Virbac. The share of the top 3 players in the Veterinary Pharmacovigilance market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Veterinary Pharmacovigilance market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. In-house accounted for XX% of Veterinary Pharmacovigilance market in 2023. Contract Outsourcing share of XX%.
Dogs accounted for XX% of the Veterinary Pharmacovigilance market in 2023. Cats accounts for XX%.
This Veterinary Pharmacovigilance market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.
Veterinary Pharmacovigilance market country level analysis
The countries covered in the Veterinary Pharmacovigilance market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.
Competitive Landscape and Veterinary Pharmacovigilance Market Share Analysis
Veterinary Pharmacovigilance market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Veterinary Pharmacovigilance market.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the Veterinary Pharmacovigilance industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of Veterinary Pharmacovigilance market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapters 4-6: Segmented the global Veterinary Pharmacovigilance market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Veterinary Pharmacovigilance market type, application, country and player market segmentation data, and include SWOT Analysis.
Chapter 12: Analyzes the Veterinary Pharmacovigilance business cost, including industrial chain and the proportion of business cost structure.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa
Player list
Zoetis Inc.
Merck & Co., Inc. (Merck Animal Health)
Boehringer Ingelheim Animal Health
Elanco Animal Health
Virbac
Bayer Animal Health
Ceva Santé Animale
Vetoquinol
IDEXX Laboratories, Inc.
Covetrus
Norbrook Laboratories
Dechra Pharmaceuticals PLC
Merial (now part of Boehringer Ingelheim)
Huvepharma
Biovet JSC
Types list
In-house
Contract Outsourcing
Application list
Dogs
Cats
Others
Table of Content
1 Market Overview
1.1 Veterinary Pharmacovigilance Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Veterinary Pharmacovigilance Market Size & Forecast
1.4.1 Global Veterinary Pharmacovigilance Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Veterinary Pharmacovigilance Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Veterinary Pharmacovigilance Market Drivers
1.5.2 Veterinary Pharmacovigilance Market Restraints
1.5.3 Veterinary Pharmacovigilance Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Zoetis Inc.
2.1.1 Business Overview
2.1.2 Zoetis Inc. SWOT Analysis
2.1.3 Zoetis Inc. Veterinary Pharmacovigilance Products and Service Offered
2.1.4 Zoetis Inc. Veterinary Pharmacovigilance Revenue and Gross Margin
2.2 Merck & Co., Inc. (Merck Animal Health)
2.2.1 Business Overview
2.2.2 Merck & Co., Inc. (Merck Animal Health) SWOT Analysis
2.2.3 Merck & Co., Inc. (Merck Animal Health) Veterinary Pharmacovigilance Products and Service Offered
2.2.4 Merck & Co., Inc. (Merck Animal Health) Veterinary Pharmacovigilance Revenue and Gross Margin
2.3 Boehringer Ingelheim Animal Health
2.3.1 Business Overview
2.3.2 Boehringer Ingelheim Animal Health SWOT Analysis
2.3.3 Boehringer Ingelheim Animal Health Veterinary Pharmacovigilance Products and Service Offered
2.3.4 Boehringer Ingelheim Animal Health Veterinary Pharmacovigilance Revenue and Gross Margin
2.4 Elanco Animal Health
2.4.1 Business Overview
2.4.2 Elanco Animal Health SWOT Analysis
2.4.3 Elanco Animal Health Veterinary Pharmacovigilance Products and Service Offered
2.4.4 Elanco Animal Health Veterinary Pharmacovigilance Revenue and Gross Margin
2.5 Virbac
2.5.1 Business Overview
2.5.2 Virbac SWOT Analysis
2.5.3 Virbac Veterinary Pharmacovigilance Products and Service Offered
2.5.4 Virbac Veterinary Pharmacovigilance Revenue and Gross Margin
2.6 Bayer Animal Health
2.6.1 Business Overview
2.6.2 Bayer Animal Health SWOT Analysis
2.6.3 Bayer Animal Health Veterinary Pharmacovigilance Products and Service Offered
2.6.4 Bayer Animal Health Veterinary Pharmacovigilance Revenue and Gross Margin
2.7 Ceva Santé Animale
2.7.1 Business Overview
2.7.2 Ceva Santé Animale SWOT Analysis
2.7.3 Ceva Santé Animale Veterinary Pharmacovigilance Products and Service Offered
2.7.4 Ceva Santé Animale Veterinary Pharmacovigilance Revenue and Gross Margin
2.8 Vetoquinol
2.8.1 Business Overview
2.8.2 Vetoquinol SWOT Analysis
2.8.3 Vetoquinol Veterinary Pharmacovigilance Products and Service Offered
2.8.4 Vetoquinol Veterinary Pharmacovigilance Revenue and Gross Margin
2.9 IDEXX Laboratories, Inc.
2.9.1 Business Overview
2.9.2 IDEXX Laboratories, Inc. SWOT Analysis
2.9.3 IDEXX Laboratories, Inc. Veterinary Pharmacovigilance Products and Service Offered
2.9.4 IDEXX Laboratories, Inc. Veterinary Pharmacovigilance Revenue and Gross Margin
2.10 Covetrus
2.10.1 Business Overview
2.10.2 Covetrus SWOT Analysis
2.10.3 Covetrus Veterinary Pharmacovigilance Products and Service Offered
2.10.4 Covetrus Veterinary Pharmacovigilance Revenue and Gross Margin
2.11 Norbrook Laboratories
2.11.1 Business Overview
2.11.2 Norbrook Laboratories SWOT Analysis
2.11.3 Norbrook Laboratories Veterinary Pharmacovigilance Products and Service Offered
2.11.4 Norbrook Laboratories Veterinary Pharmacovigilance Revenue and Gross Margin
2.12 Dechra Pharmaceuticals PLC
2.12.1 Business Overview
2.12.2 Dechra Pharmaceuticals PLC SWOT Analysis
2.12.3 Dechra Pharmaceuticals PLC Veterinary Pharmacovigilance Products and Service Offered
2.12.4 Dechra Pharmaceuticals PLC Veterinary Pharmacovigilance Revenue and Gross Margin
2.13 Merial (now part of Boehringer Ingelheim)
2.13.1 Business Overview
2.13.2 Merial (now part of Boehringer Ingelheim) SWOT Analysis
2.13.3 Merial (now part of Boehringer Ingelheim) Veterinary Pharmacovigilance Products and Service Offered
2.13.4 Merial (now part of Boehringer Ingelheim) Veterinary Pharmacovigilance Revenue and Gross Margin
2.14 Huvepharma
2.14.1 Business Overview
2.14.2 Huvepharma SWOT Analysis
2.14.3 Huvepharma Veterinary Pharmacovigilance Products and Service Offered
2.14.4 Huvepharma Veterinary Pharmacovigilance Revenue and Gross Margin
2.15 Biovet JSC
2.15.1 Business Overview
2.15.2 Biovet JSC SWOT Analysis
2.15.3 Biovet JSC Veterinary Pharmacovigilance Products and Service Offered
2.15.4 Biovet JSC Veterinary Pharmacovigilance Revenue and Gross Margin
3 Global Veterinary Pharmacovigilance Market Competition, by Manufacturer
3.1 Global Veterinary Pharmacovigilance Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Veterinary Pharmacovigilance Players Market Share in 2023
3.2.2 Top 6 Veterinary Pharmacovigilance Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Veterinary Pharmacovigilance Players Head Office, Business Provided
3.4 Veterinary Pharmacovigilance Mergers & Acquisitions
3.5 Veterinary Pharmacovigilance New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Veterinary Pharmacovigilance Revenue in Value by Type (2019-2030)
4.2 Global Veterinary Pharmacovigilance Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Veterinary Pharmacovigilance Revenue by Application (2019-2030)
5.2 Global Veterinary Pharmacovigilance Revenue Share by Application (2019-2030)
6 Global Veterinary Pharmacovigilance Market Analysis by Regions
6.1 Global Veterinary Pharmacovigilance Revenue and Market Share by Regions
6.1.1 Global Veterinary Pharmacovigilance Revenue by Regions (2019-2030)
6.1.2 Global Veterinary Pharmacovigilance Revenue Market Share by Regions (2019-2030)
6.2 North America Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
6.3 Europe Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
6.4 Asia Pacific Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
6.5 South America Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
6.6 Middle East and Africa Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
7 North America Veterinary Pharmacovigilance by Country, by Type, and by Application
7.1 North America Veterinary Pharmacovigilance Revenue by Type (2019-2030)
7.2 North America Veterinary Pharmacovigilance Revenue by Application (2019-2030)
7.3 North America Veterinary Pharmacovigilance Revenue and Market Share by Countries
7.3.1 North America Veterinary Pharmacovigilance Revenue in Value by Country (2019-2030)
7.3.2 United States Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
7.3.3 Canada Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
7.3.4 Mexico Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Veterinary Pharmacovigilance by Country, by Type, and by Application
8.1 Europe Veterinary Pharmacovigilance Revenue by Type (2019-2030)
8.2 Europe Veterinary Pharmacovigilance Revenue by Application (2019-2030)
8.3 Europe Veterinary Pharmacovigilance Revenue and Market Share by Countries
8.3.1 Europe Veterinary Pharmacovigilance Revenue in Value by Country (2019-2030)
8.3.2 Germany Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
8.3.3 France Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
8.3.4 United Kingdom Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
8.3.5 Russia Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
8.3.6 Italy Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
8.3.7 Nordic Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Veterinary Pharmacovigilance by Country, by Type, and by Application
9.1 Asia Pacific Veterinary Pharmacovigilance Revenue by Type (2019-2030)
9.2 Asia Pacific Veterinary Pharmacovigilance Revenue by Application (2019-2030)
9.3 Asia Pacific Veterinary Pharmacovigilance Revenue and Market Share by Countries
9.3.1 Asia Pacific Veterinary Pharmacovigilance Revenue in Value by Country (2019-2030)
9.3.2 China Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
9.3.3 Japan Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
9.3.4 Korea Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
9.3.5 India Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
9.3.7 Australia Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Veterinary Pharmacovigilance by Country, by Type, and by Application
10.1 South America Veterinary Pharmacovigilance Revenue by Type (2019-2030)
10.2 South America Veterinary Pharmacovigilance Revenue by Application (2019-2030)
10.3 South America Veterinary Pharmacovigilance Revenue and Market Share by Countries
10.3.1 South America Veterinary Pharmacovigilance Revenue in Value by Country (2019-2030)
10.3.2 Brazil Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
10.3.3 Argentina Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Veterinary Pharmacovigilance by Country, by Type, and by Application
11.1 Middle East & Africa Veterinary Pharmacovigilance Revenue by Type (2019-2030)
11.2 Middle East & Africa Veterinary Pharmacovigilance Revenue by Application (2019-2030)
11.3 Middle East & Africa Veterinary Pharmacovigilance Revenue and Market Share by Countries
11.3.1 Middle East & Africa Veterinary Pharmacovigilance Revenue in Value by Country (2019-2030)
11.3.2 Turkey Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
11.3.3 Egypt Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
11.3.5 UAE Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
11.3.6 South Africa Veterinary Pharmacovigilance Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Veterinary Pharmacovigilance Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Veterinary Pharmacovigilance Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer